PT1265911E - 17-alfa-substituída-11-beta-substituída-4-aril e 21- substituída 19-norpregnadienodiona enquanto agentes antiprogestativos - Google Patents
17-alfa-substituída-11-beta-substituída-4-aril e 21- substituída 19-norpregnadienodiona enquanto agentes antiprogestativos Download PDFInfo
- Publication number
- PT1265911E PT1265911E PT01918812T PT01918812T PT1265911E PT 1265911 E PT1265911 E PT 1265911E PT 01918812 T PT01918812 T PT 01918812T PT 01918812 T PT01918812 T PT 01918812T PT 1265911 E PT1265911 E PT 1265911E
- Authority
- PT
- Portugal
- Prior art keywords
- substituted
- beta
- aryl
- alpha
- norpregnadienedione
- Prior art date
Links
- 230000001911 anti-progestational effect Effects 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/526,855 US6900193B1 (en) | 1996-05-01 | 2000-03-17 | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1265911E true PT1265911E (pt) | 2008-10-09 |
Family
ID=24099075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01918812T PT1265911E (pt) | 2000-03-17 | 2001-03-16 | 17-alfa-substituída-11-beta-substituída-4-aril e 21- substituída 19-norpregnadienodiona enquanto agentes antiprogestativos |
Country Status (11)
| Country | Link |
|---|---|
| EP (4) | EP2348030B1 (enExample) |
| JP (2) | JP5417562B2 (enExample) |
| AT (1) | ATE396197T1 (enExample) |
| AU (2) | AU4584901A (enExample) |
| CA (1) | CA2403756C (enExample) |
| CY (1) | CY1108281T1 (enExample) |
| DE (1) | DE60134126D1 (enExample) |
| DK (1) | DK1265911T3 (enExample) |
| ES (3) | ES2546336T3 (enExample) |
| PT (1) | PT1265911E (enExample) |
| WO (1) | WO2001074840A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE396197T1 (de) * | 2000-03-17 | 2008-06-15 | Us Gov Health & Human Serv | 17-alpha-substituierte-11-beta-substituierte-4- aryl und 21-substituierte 19-norpregnadienedione mit antigestagener aktivität |
| ES2212912B1 (es) * | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
| US8173626B2 (en) * | 2006-03-08 | 2012-05-08 | Danco Laboratories Llc | Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders |
| MY150763A (en) * | 2006-10-24 | 2014-02-28 | Repros Therapeutics Inc | Compositions and methods for suppressing endometrial proliferation |
| HU228636B1 (en) | 2007-06-27 | 2013-04-29 | Richter Gedeon Nyrt | Industrial method for the synthesis of 17-acetoxy-11betha-4[-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
| TWI477276B (zh) * | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
| TWI539953B (zh) * | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
| TW201002736A (en) * | 2008-04-28 | 2010-01-16 | Repros Therapeutics Inc | Compositions and methods for treating progesterone-dependent conditions |
| HUP0900171A2 (hu) | 2009-03-20 | 2010-12-28 | Richter Gedeon Nyrt | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos módosulata és eljárás elõállítására |
| WO2010119029A1 (en) * | 2009-04-14 | 2010-10-21 | Laboratoire Hra-Pharma | Method for on-demand contraception |
| HUP0900487A2 (hu) | 2009-08-05 | 2011-03-28 | Richter Gedeon Nyrt | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására |
| UA113283C2 (xx) * | 2010-12-23 | 2017-01-10 | 19-норстероїди і їх застосування для лікування прогестеронзалежних станів | |
| CN102516345B (zh) * | 2011-11-01 | 2014-11-26 | 上海优拓医药科技有限公司 | 醋酸乌利司他及其关键中间体的制备方法 |
| US9109005B2 (en) * | 2012-02-23 | 2015-08-18 | Boehringer Ingelheim International Gmbh | Method for manufacturing of ciclesonide |
| CA2872644A1 (en) | 2012-05-31 | 2013-12-05 | Allergan Pharmaceuticals International Limited | Formulations and methods for vaginal delivery of antiprogestins |
| CN102702296B (zh) * | 2012-06-19 | 2014-09-03 | 山东诚创医药技术开发有限公司 | 环-3,20-双(1,2-亚乙基缩醛)-17α-羟基-17β-乙酰基-雌甾-5(10),9(11)-二烯-3-酮的制备方法 |
| CN102942612A (zh) * | 2012-10-30 | 2013-02-27 | 四川大学 | 一种合成醋酸乌利司他的新方法 |
| US9545411B2 (en) | 2012-11-02 | 2017-01-17 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
| CN103073612B (zh) * | 2013-02-04 | 2015-11-04 | 山东大学 | 醋酸乌利司他关键中间体的制备方法 |
| HU230319B1 (hu) | 2013-10-01 | 2016-01-28 | Richter Gedeon Nyrt. | Ipari eljárás szteroid hatóanyagok előállítására |
| CN104774231A (zh) * | 2014-01-13 | 2015-07-15 | 上海医药工业研究院 | 17α-羟基-19-去甲孕甾-4,9-二烯-3,20-二酮的制备工艺 |
| HU230381B1 (hu) | 2014-02-17 | 2016-03-29 | Richter Gedeon Nyrt | Ipari eljárás szteroid intermedier előállítására |
| CN107840865A (zh) * | 2016-09-20 | 2018-03-27 | 天津金耀集团有限公司 | 一种甲泼尼龙的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS582607B2 (ja) | 1976-03-12 | 1983-01-18 | パイオニア株式会社 | 温度検知回路 |
| FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
| DE3321826A1 (de) * | 1983-06-15 | 1984-12-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE3504421A1 (de) * | 1985-02-07 | 1986-08-07 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate |
| CA1317283C (en) | 1986-11-05 | 1993-05-04 | Douglas Alan Livingston | Steroidal 17-silyl ethers and process to corticoids and progesterones |
| US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
| US5929262A (en) * | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
| ES2152671T3 (es) * | 1996-05-01 | 2001-02-01 | Us Gov Health & Human Serv | Derivados de progesterona sustituidos en posicion 21 como nuevos agentes antiprogestacionales. |
| US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| US6172052B1 (en) * | 1998-12-04 | 2001-01-09 | Research Triangle Institute | 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| US6740645B1 (en) * | 1999-09-03 | 2004-05-25 | Research Triangle Institute | 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
| ATE396197T1 (de) * | 2000-03-17 | 2008-06-15 | Us Gov Health & Human Serv | 17-alpha-substituierte-11-beta-substituierte-4- aryl und 21-substituierte 19-norpregnadienedione mit antigestagener aktivität |
| RU38486U1 (ru) | 2003-11-03 | 2004-06-20 | Закрытое акционерное общество "Пермский проектно-конструкторский и экспериментальный институт горного и нефтяного машиностроения" | Гидропривод путеочистительной машины |
-
2001
- 2001-03-16 AT AT01918812T patent/ATE396197T1/de active
- 2001-03-16 ES ES10010647.5T patent/ES2546336T3/es not_active Expired - Lifetime
- 2001-03-16 ES ES01918812T patent/ES2307604T3/es not_active Expired - Lifetime
- 2001-03-16 PT PT01918812T patent/PT1265911E/pt unknown
- 2001-03-16 AU AU4584901A patent/AU4584901A/xx active Pending
- 2001-03-16 DK DK01918812T patent/DK1265911T3/da active
- 2001-03-16 JP JP2001572529A patent/JP5417562B2/ja not_active Expired - Fee Related
- 2001-03-16 EP EP20100010647 patent/EP2348030B1/en not_active Expired - Lifetime
- 2001-03-16 EP EP10010646.7A patent/EP2348031B9/en not_active Expired - Lifetime
- 2001-03-16 DE DE60134126T patent/DE60134126D1/de not_active Expired - Lifetime
- 2001-03-16 CA CA2403756A patent/CA2403756C/en not_active Expired - Lifetime
- 2001-03-16 EP EP01918812A patent/EP1265911B1/en not_active Expired - Lifetime
- 2001-03-16 EP EP08009259A patent/EP2033965A3/en not_active Withdrawn
- 2001-03-16 ES ES10010646.7T patent/ES2546291T3/es not_active Expired - Lifetime
- 2001-03-16 WO PCT/US2001/008681 patent/WO2001074840A2/en not_active Ceased
- 2001-03-16 AU AU2001245849A patent/AU2001245849B2/en not_active Expired
-
2008
- 2008-08-21 CY CY20081100895T patent/CY1108281T1/el unknown
-
2011
- 2011-11-07 JP JP2011244014A patent/JP2012051935A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2033965A3 (en) | 2012-09-19 |
| EP2348030A2 (en) | 2011-07-27 |
| ES2546336T3 (es) | 2015-09-22 |
| EP2348031B9 (en) | 2016-08-10 |
| AU4584901A (en) | 2001-10-15 |
| EP1265911B1 (en) | 2008-05-21 |
| DK1265911T3 (da) | 2008-09-29 |
| EP2348031A3 (en) | 2012-05-09 |
| JP5417562B2 (ja) | 2014-02-19 |
| ATE396197T1 (de) | 2008-06-15 |
| EP2348031A2 (en) | 2011-07-27 |
| EP2348031B1 (en) | 2015-06-17 |
| WO2001074840A2 (en) | 2001-10-11 |
| JP2003529604A (ja) | 2003-10-07 |
| DE60134126D1 (de) | 2008-07-03 |
| WO2001074840A3 (en) | 2002-05-02 |
| JP2012051935A (ja) | 2012-03-15 |
| EP2348030A3 (en) | 2012-05-09 |
| EP1265911A2 (en) | 2002-12-18 |
| CA2403756A1 (en) | 2001-10-11 |
| EP2348030B1 (en) | 2015-05-06 |
| EP2033965A2 (en) | 2009-03-11 |
| ES2307604T3 (es) | 2008-12-01 |
| CY1108281T1 (el) | 2014-02-12 |
| CA2403756C (en) | 2010-02-09 |
| AU2001245849B2 (en) | 2007-01-04 |
| ES2546291T3 (es) | 2015-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2348031A3 (en) | 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents | |
| ZA200204165B (en) | Fulvestrant formulation. | |
| YU15299A (sh) | Farmaceutski sastavi | |
| MXPA03004932A (es) | 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe. | |
| MXPA03008164A (es) | Agentes anti-epileptogenos. | |
| TW507842U (en) | Combination type fan | |
| MY135452A (en) | 2-methyl-thieno-benzodiazepine lyophilized formulation | |
| SG88815A1 (en) | Deodorizer using ozone and refrigerator with the same | |
| GB2347303B (en) | My invention the magmobelt | |
| PL370867A1 (en) | Reduced toxicity cisplatin formulations and methods for using the same | |
| GB0006787D0 (en) | The ecotruck | |
| GB0024885D0 (en) | The space-finder | |
| GB0011320D0 (en) | The zeroclick invention | |
| GB0004772D0 (en) | The blower | |
| MXPA03005251A (es) | Agentes antilipemicos. | |
| ZA200401572B (en) | 3-phenoxyl-4-pyridazinol derivative and herbicide compsition containing the same. | |
| GB0011322D0 (en) | The zeroclick invention | |
| GB0012580D0 (en) | The zeroclick invention | |
| GB0012582D0 (en) | The zeroclick invention | |
| AU2169P (en) | CATT 1 Solanum rantonetii | |
| GB9818584D0 (en) | Educational aid or the like | |
| CA92671S (en) | Blower | |
| ZA200106264B (en) | The assessment of students. | |
| GB0017837D0 (en) | The ultimate joyrider | |
| ZA200201279B (en) | Anti-HIV agents. |